Literature DB >> 1587607

Protection of Aotus monkeys from malaria infection by immunization with recombinant hybrid proteins.

B Knapp1, E Hundt, B Enders, H A Küpper.   

Abstract

On the basis of investigations of the malarial blood-stage antigens SERP, HRPII, and MSAI from Plasmodium falciparum, we chose two Escherichia coli-expressed hybrid proteins containing selected partial sequences of these antigens. Antibodies raised against both hybrid proteins in rabbits and Aotus monkeys recognize the corresponding P. falciparum polypeptides. In two independent trials with 13 animals, immunization of Aotus monkeys with either of the two hybrid proteins administered in a well-tolerated oil-based formulation protected the animals from an experimental P. falciparum infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587607      PMCID: PMC257172          DOI: 10.1128/iai.60.6.2397-2401.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Responses of T cells from sensitized donors to recombinant and synthetic peptides corresponding to sequences of the Plasmodium falciparum SERP antigen.

Authors:  C Roussilhon; E Hundt; M Agrapart; W Stüber; B Knapp; P Dubois; J J Ballet
Journal:  Immunol Lett       Date:  1990-08       Impact factor: 3.685

2.  Amino acid sequence of the serine-repeat antigen (SERA) of Plasmodium falciparum determined from cloned cDNA.

Authors:  D J Bzik; W B Li; T Horii; J Inselburg
Journal:  Mol Biochem Parasitol       Date:  1988-09       Impact factor: 1.759

3.  Variation in the precursor to the major merozoite surface antigens of Plasmodium falciparum.

Authors:  M G Peterson; R L Coppel; P McIntyre; C J Langford; G Woodrow; G V Brown; R F Anders; D J Kemp
Journal:  Mol Biochem Parasitol       Date:  1988-01-15       Impact factor: 1.759

4.  Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension.

Authors:  R M Horton; H D Hunt; S N Ho; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

5.  Mechanism of action of the lexA gene product.

Authors:  R Brent; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

6.  A histidin alanine rich recombinant antigen protects Aotus monkeys from P. falciparum infection.

Authors:  B Knapp; A Shaw; E Hundt; B Enders; H A Küpper
Journal:  Behring Inst Mitt       Date:  1988-04

7.  A new blood stage antigen of Plasmodium falciparum highly homologous to the serine-stretch protein SERP.

Authors:  B Knapp; U Nau; E Hundt; H A Küpper
Journal:  Mol Biochem Parasitol       Date:  1991-01       Impact factor: 1.759

8.  Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria.

Authors:  W A Siddiqui; L Q Tam; K J Kramer; G S Hui; S E Case; K M Yamaga; S P Chang; E B Chan; S C Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

9.  Protective immunity induced in Aotus monkeys by recombinant SERA proteins of Plasmodium falciparum.

Authors:  J Inselburg; D J Bzik; W B Li; K M Green; J Kansopon; B K Hahm; I C Bathurst; P J Barr; R N Rossan
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

10.  Epitopes recognized by human T cells map within the conserved part of the GP190 of P. falciparum.

Authors:  A Crisanti; H M Müller; C Hilbich; F Sinigaglia; H Matile; M McKay; J Scaife; K Beyreuther; H Bujard
Journal:  Science       Date:  1988-06-03       Impact factor: 47.728

View more
  11 in total

1.  Conservation of Babesia bovis small heat shock protein (Hsp20) among strains and definition of T helper cell epitopes recognized by cattle with diverse major histocompatibility complex class II haplotypes.

Authors:  Junzo Norimine; Juan Mosqueda; Guy H Palmer; Harris A Lewin; Wendy C Brown
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

2.  Immunogenicity of four Plasmodium falciparum preerythrocytic antigens in Aotus lemurinus monkeys.

Authors:  B L Perlaza; M Arévalo-Herrera; K Brahimi; G Quintero; J C Palomino; H Gras-Masse; A Tartar; P Druilhe; S Herrera
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

3.  H-2b restriction of the immune response to the p126 Plasmodium falciparum antigen.

Authors:  D M Banic; P Delplace; C Mazingue; D Camus
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

4.  Immunization of Aotus monkeys with recombinant Plasmodium falciparum hybrid proteins does not reproducibly result in protection from malaria infection.

Authors:  C H Kocken; E Hundt; B Knapp; D Brazel; B Enders; D L Narum; J A Wubben; A W Thomas
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

5.  Conservation of antigen components from two recombinant hybrid proteins protective against malaria.

Authors:  B Knapp; U Nau; E Hundt
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

Review 6.  Malaria vaccine development.

Authors:  T R Jones; S L Hoffman
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

7.  A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.

Authors:  S P Chang; S E Case; W L Gosnell; A Hashimoto; K J Kramer; L Q Tam; C Q Hashiro; C M Nikaido; H L Gibson; C T Lee-Ng; P J Barr; B T Yokota; G S Hut
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

8.  Induction of opsonizing antibodies after injection of recombinant Plasmodium falciparum vaccine candidate antigens in preimmune Saimiri sciureus monkeys.

Authors:  R Perraut; O Mercereau-Puijalon; D Mattei; E Bourreau; O Garraud; B Bonnemains; L Pereia de Silva; J C Michel
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

Review 9.  Malaria vaccines.

Authors:  A A Holder
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 10.  Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens.

Authors:  Nicola Clementi; Nicasio Mancini; Laura Solforosi; Matteo Castelli; Massimo Clementi; Roberto Burioni
Journal:  Int J Mol Sci       Date:  2012-07-04       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.